Epstein AL - Search Results

1

Immune signatures of murine and human cancers reveal unique mechanisms of tumor escape and new targets for cancer immunotherapy.

Sadun RE, Sachsman SM, Chen X, Christenson KW, Morris WZ, Hu P, Epstein AL. Sadun RE, et al. Among authors: epstein al. Clin Cancer Res. 2007 Jul 1;13(13):4016-25. doi: 10.1158/1078-0432.CCR-07-0016. Clin Cancer Res. 2007. PMID: 17606736

2

Complete regression of experimental solid tumors by combination LEC/chTNT-3 immunotherapy and CD25(+) T-cell depletion.

Li J, Hu P, Khawli LA, Epstein AL. Li J, et al. Among authors: epstein al. Cancer Res. 2003 Dec 1;63(23):8384-92. Cancer Res. 2003. PMID: 14679000

3

NHS76/PEP2, a fully human vasopermeability-enhancing agent to increase the uptake and efficacy of cancer chemotherapy.

Khawli LA, Hu P, Epstein AL. Khawli LA, et al. Among authors: epstein al. Clin Cancer Res. 2005 Apr 15;11(8):3084-93. doi: 10.1158/1078-0432.CCR-04-2310. Clin Cancer Res. 2005. PMID: 15837764

4

Combination B7-Fc fusion protein treatment and Treg cell depletion therapy.

Liu A, Hu P, Khawli LA, Epstein AL. Liu A, et al. Among authors: epstein al. Clin Cancer Res. 2005 Dec 1;11(23):8492-502. doi: 10.1158/1078-0432.CCR-05-1411. Clin Cancer Res. 2005. PMID: 16322313

5

Targeted and untargeted CD137L fusion proteins for the immunotherapy of experimental solid tumors.

Zhang N, Sadun RE, Arias RS, Flanagan ML, Sachsman SM, Nien YC, Khawli LA, Hu P, Epstein AL. Zhang N, et al. Among authors: epstein al. Clin Cancer Res. 2007 May 1;13(9):2758-67. doi: 10.1158/1078-0432.CCR-06-2343. Epub 2007 Apr 25. Clin Cancer Res. 2007. PMID: 17460060

6

Construction and preclinical characterization of Fc-mGITRL for the immunotherapy of cancer.

Hu P, Arias RS, Sadun RE, Nien YC, Zhang N, Sabzevari H, Lutsiak ME, Khawli LA, Epstein AL. Hu P, et al. Among authors: epstein al. Clin Cancer Res. 2008 Jan 15;14(2):579-88. doi: 10.1158/1078-0432.CCR-07-0940. Clin Cancer Res. 2008. PMID: 18223234

7

LEC/chTNT-3 fusion protein for the immunotherapy of experimental solid tumors.

Li J, Hu P, Khawli LA, Epstein AL. Li J, et al. Among authors: epstein al. J Immunother. 2003 Jul-Aug;26(4):320-31. doi: 10.1097/00002371-200307000-00004. J Immunother. 2003. PMID: 12843794

8

Comparison of three different targeted tissue factor fusion proteins for inducing tumor vessel thrombosis.

Hu P, Yan J, Sharifi J, Bai T, Khawli LA, Epstein AL. Hu P, et al. Among authors: epstein al. Cancer Res. 2003 Aug 15;63(16):5046-53. Cancer Res. 2003. PMID: 12941833

9

Chimeric TNT-3 antibody/murine interferon-gamma fusion protein for the immunotherapy of solid malignancies.

Mizokami MM, Hu P, Khawli LA, Li J, Epstein AL. Mizokami MM, et al. Among authors: epstein al. Hybrid Hybridomics. 2003 Aug;22(4):197-207. doi: 10.1089/153685903322328929. Hybrid Hybridomics. 2003. PMID: 14511565

10

chTNT-3/hu IL-12 fusion protein for the immunotherapy of experimental solid tumors.

Li J, Hu P, Khawli LA, Yun A, Epstein AL. Li J, et al. Among authors: epstein al. Hybrid Hybridomics. 2004 Feb;23(1):1-10. doi: 10.1089/153685904322771962. Hybrid Hybridomics. 2004. PMID: 15000842

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

293 results

Search Page

Filters